| |
Dead |
% |
Not-dead |
% |
All |
% |
| Age group |
|
|
|
|
|
|
| 20-49 |
7 |
15.6 |
41 |
18.7 |
48 |
18.2 |
| 50-64 |
16 |
35.6 |
67 |
30.6 |
83 |
31.4 |
| 65-74 |
9 |
20.0 |
49 |
22.4 |
58 |
22.0 |
| 75+ |
13 |
28.9 |
62 |
28.3 |
75 |
28.4 |
| Sex |
|
|
|
|
|
|
| Male |
26 |
57.8 |
110 |
50.2 |
136 |
51.5 |
| Female |
19 |
42.2 |
109 |
49.8 |
128 |
48.5 |
| Year of diagnosis |
|
|
|
|
|
|
| 1996-1999 |
23 |
51.1 |
92 |
42.0 |
115 |
43.6 |
| 2000-2003 |
22 |
48.9 |
127 |
58.0 |
149 |
56.4 |
| Tumor thickness1 |
|
|
|
|
|
|
| 0-0.99 mm |
5 |
11.4 |
42 |
24.6 |
47 |
21.9 |
| 1-1.99 mm |
4 |
9.1 |
51 |
29.8 |
55 |
25.6 |
| 2-2.99 mm |
7 |
15.9 |
24 |
14.0 |
31 |
14.4 |
| 3-3.99 mm |
6 |
13.6 |
13 |
7.6 |
19 |
8.8 |
| 4+ mm |
19 |
43.2 |
29 |
17.0 |
48 |
22.3 |
| Missing data |
3 |
6.8 |
12 |
7.0 |
15 |
7.0 |
| Clark level |
|
|
|
|
|
|
| I |
1 |
2.2 |
56 |
25.6 |
57 |
21.6 |
| II |
1 |
2.2 |
30 |
13.7 |
31 |
11.7 |
| III |
14 |
31.1 |
63 |
28.8 |
77 |
29.2 |
| IV |
20 |
44.4 |
56 |
25.6 |
76 |
28.8 |
| V |
7 |
15.6 |
9 |
4.1 |
16 |
6.1 |
| Missing data |
2 |
4.4 |
5 |
2.3 |
7 |
2.7 |
| Ulceration |
|
|
|
|
|
|
| No ulceration |
14 |
31.1 |
125 |
57.1 |
139 |
52.7 |
| Ulceration |
27 |
60.0 |
43 |
19.6 |
70 |
26.5 |
| Missing data |
4 |
8.9 |
51 |
23.3 |
55 |
20.8 |
| Histopathology |
|
|
|
|
|
|
| NM |
22 |
48.9 |
47 |
21.5 |
69 |
26.1 |
| SSM |
17 |
37.8 |
77 |
35.2 |
94 |
35.6 |
| In situ |
1 |
2.2 |
48 |
21.9 |
49 |
18.6 |
| Others |
1 |
2.2 |
25 |
11.4 |
26 |
9.8 |
| Missing data |
4 |
8.9 |
22 |
10.0 |
26 |
9.8 |
| Node status |
|
|
|
|
|
|
| N0 |
29 |
64.4 |
212 |
96.8 |
241 |
91.3 |
| N+ |
15 |
33.3 |
5 |
2.3 |
20 |
7.6 |
| NX |
1 |
2.2 |
2 |
0.9 |
3 |
1.1 |
| Fraction (%) |
|
|
|
|
|
|
| 0 (0) |
1 |
2.2 |
8 |
3.7 |
9 |
3.4 |
| 1-25 (1) |
9 |
20.0 |
18 |
8.2 |
27 |
10.2 |
| 25-75 (2) |
11 |
24.4 |
36 |
16.4 |
47 |
17.8 |
| 75-100 (3) |
24 |
53.3 |
152 |
69.4 |
176 |
66.7 |
| Missing data |
0 |
|
5 |
2.3 |
5 |
1.9 |
| Intensity of staining |
|
|
|
|
|
|
| Negative (0) |
1 |
2.2 |
8 |
3.7 |
9 |
3.4 |
| Weak (1) |
7 |
15.6 |
14 |
6.4 |
21 |
8.0 |
| Strong (2) |
37 |
82.2 |
192 |
87.7 |
229 |
86.7 |
| Missing data |
0 |
|
5 |
2.3 |
5 |
1.9 |
| MITF Fraction/Intensity |
|
|
|
|
|
|
| 3/2 |
22 |
48.9 |
146 |
66.7 |
168 |
63.6 |
| 2/2 |
7 |
15.6 |
31 |
14.2 |
38 |
14.4 |
| 3/1 |
2 |
4.4 |
6 |
2.7 |
8 |
3.0 |
| 2/1 |
4 |
8.9 |
5 |
2.3 |
9 |
3.4 |
| 1/2 |
8 |
17.8 |
15 |
6.8 |
23 |
8.7 |
| 1/1 |
1 |
2.2 |
3 |
1.4 |
4 |
1.5 |
| 0/0 |
1 |
2.2 |
8 |
3.7 |
9 |
3.4 |
| Missing data |
0 |
|
5 |
2.3 |
5 |
1.9 |
1Applies to invasive tumors
NM: Nodular malignant melanoma, SSM: Superficial spreading melanoma |
